Compugen Stock

Compugen Debt Growth

The Year-over-Year Debt Growth of Compugen (CGEN) as of Sep 8, 2026 is -41.16 %. In the previous year, Year-over-Year Debt Growth was -105.40 % — a change of -60.95% (higher).

Debt Growth

-41.16 %

YoY

-60.95%

Last updated:

Year-over-Year Debt Growth of Compugen is 2026 -41.16 % . Year-over-Year Debt Growth of Compugen was 2025 -105.40 % . It decreases by -60.95% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Year-over-Year Debt Growth of Compugen is -41.16 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Compugen since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Compugen historically and in real time.

Access this data via the Eulerpool API

Growth — Compugen

All Key Metrics — Compugen